Edition:
United Kingdom

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

5.33USD
18 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.33
Open
$5.52
Day's High
$5.52
Day's Low
$5.27
Volume
50,117
Avg. Vol
137,385
52-wk High
$10.70
52-wk Low
$4.98

Chart for

About

Bellicum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The Company uses its chemical induction of... (more)

Overall

Beta: --
Market Cap(Mil.): $377.79
Shares Outstanding(Mil.): 33.23
Dividend: --
Yield (%): --

Financials

  BLCM.OQ Industry Sector
P/E (TTM): -- 85.83 33.69
EPS (TTM): -2.94 -- --
ROI: -56.99 0.58 14.30
ROE: -67.22 1.62 16.03

BRIEF-Bellicum Pharmaceuticals Reports Q1 Loss Per Share Of $0.68

* BELLICUM PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

08 May 2018

Earnings vs. Estimates